Peptides DB
Research-centric peptide and protocol reference hub
Study 8 of 17Thymosin Alpha-1 literaturebiorxiv-preprint · Observational2024

Local inflammation at the salmon louse (Lepeophtheirus salmonis) attachment site drives copepodid rejection in Coho Salmon (Oncorhynchus kisutch)

Coho Salmon can reject copepodids after two days, which is linked to a strong immune response at the attachment sites. This response differs significantly from that of Atlantic Salmon.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the thymosin alpha-1 corpus
2
Preclinical
12
Observational · this one
0
Open-label
2
Randomised
1
Reviews

Summary and findings

This study investigated the dynamics of salmon louse infestation in four salmonid species, focusing on Coho Salmon (Oncorhynchus kisutch). The study found that Coho Salmon rejected copepodids after two days, linked to an influx of polymorphonuclear cells at attachment sites. Mucous cell coverage was reported as 30-40% in Chum Salmon and 10% in Atlantic Salmon.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Chum Salmon showed 30-40% mucous cell coverage compared to 10% in Atlantic Salmon.2024

Abstract

The authors’ words, as biorxiv-preprint supplied them

<title>Abstract</title> <p>Salmon louse (<italic>Lepeophtheirus salmonis</italic>) poses significant risks to both wild and farmed salmon populations. Atlantic Salmon (Salmo salar) are highly susceptible to the parasite, while Pacific salmon species such as Pink (<italic>Oncorhynchus gorbuscha</italic>), Coho (<italic>Oncorhynchus kisutch</italic>), and Chum (<italic>Oncorhynchus keta</italic>) salmon exhibit varying levels of resistance. This study explored L. salmonis infestation dynamics in four salmonid species (Atlantic, Pink, Coho, and Chum Salmon) across three challenge trials using the same fish cohort. Infestation was only successful in the third trial, where sedation facilitated parasite attachment. Skin and fin samples were collected at 12, 24, 36, 48, 60, and 168 hours post-infestation (hpi) during the early infestation phase. Results showed low L. salmonis settlement on Chum and Pink Salmon, while Coho Salmon initially had the highest lice counts on fins, followed by Atlantic Salmon. A strong correlation was observed between mucous cell area and susceptibility, with Chum Salmon showing 30-40% mucous cell coverage compared to 10% in Atlantic Salmon. Coho Salmon successfully rejected copepodids after two days, which was linked to an influx of polymorphonuclear cells at attachment sites. This immune response, highlighted by spatial transcriptomics, showed upregulation of host immune markers at the louse-host interface, suggesting that macrophages and neutrophils are key to copepodid rejection. The findings suggest that Coho Salmon’s rapid inflammatory response is crucial in resisting lice and differs significantly from the response in Atlantic Salmon.</p>

Elsewhere in the Thymosin Alpha-1 corpus

BThymosin α1-induced secretion of the IL-15/RA complex by THP-1-derived dendritic cells restrains HIV latency in vitro.Virulence · 2026 · Intracellular p24 levels in CD4+ T cells decreased significantly, p=0.002.HumanDReply to 'F508del-CFTR is not corrected by thymosin α1'.Nature medicine · 2018BF508del-CFTR is not corrected by thymosin α1.Nature medicine · 2018In vitroAThe efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial.BMJ (Clinical research ed.) · 2025 · 28-day all-cause mortality: 23.4% (127/542) in thymosin α1 group vs 24.1% (132/547) in placebo group, hazard ratio 0.99, 95% CI 0.77 to 1.27, P=0.93.HumanBProximal tubule reabsorptive dysfunction and risk of cardiovascular death among community-living adults: the HUNT-3 cohort.europepmc · 2026 · 1-SD higher urine A1M associated with HR 1.33 (95% CI 1.12-1.58) for cardiovascular death.HumanBPrecision biomarker discovery in hypertension through explainable AI and proteomics.europepmc · 2026 · AUROC = 0.7985 for CatBoost classifier.Human